Twelve informative SWR.SJL-X.CAST-4 recombinant subcongenic lines (Lines 4-1 through 4-12), with unique recombinations of the Gct1SW and Gct1CA alleles across the Gct1 locus, were successfully derived from the founder congenic Line 4-T and tested for GC tumor susceptibility with subcutaneous DHEA-filled capsules. This evidence concerns the gene INTS13 and neoplasm.